DS
Dilip Shanghvi
India · Pharmaceuticals · Sun Pharmaceutical Industries
Estimated Net Worth
$24.80B
Per Forbes, April 2026 — not a live figure
Share this
About Dilip
Borrowed a small sum from his father to start Sun Pharmaceutical Industries in 1983 making psychiatric drugs. Grew it through acquisitions, including the $4 billion purchase of Ranbaxy Laboratories in 2014, into India's most valuable listed drugmaker.
Dilip Shanghviisn't part of our live-tracked core roster — we haven't verified their public shareholdings to price them minute-to-minute, so this figure is a static, point-in-time estimate from Forbes, not derived from a live stock price like the rest of this site. See the full ranked list →